Sarepta Therapeutics Inc. (SRPT)
NASDAQ: SRPT
· Real-Time Price · USD
36.17
-1.14 (-3.06%)
At close: Jun 13, 2025, 3:59 PM
36.32
0.41%
After-hours: Jun 13, 2025, 05:59 PM EDT
-3.06% (1D)
| Bid | 36.21 |
| Market Cap | 3.55B |
| Revenue (ttm) | 2.23B |
| Net Income (ttm) | -248.39M |
| EPS (ttm) | -2.64 |
| PE Ratio (ttm) | -13.7 |
| Forward PE | 5.43 |
| Analyst | Buy |
| Ask | 36.33 |
| Volume | 2,566,385 |
| Avg. Volume (20D) | 3,863,082 |
| Open | 37.05 |
| Previous Close | 37.31 |
| Day's Range | 35.78 - 38.09 |
| 52-Week Range | 34.10 - 173.25 |
| Beta | 0.60 |
About SRPT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SRPT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SRPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+9.69%
Sarepta Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
3 weeks ago
+0.15%
Sarepta Therapeutics shares are trading higher after the company provided dosing updates on its ENVISION study of ELEVIDYS.
